PLK4 Inhibition as a Strategy to Enhance Non–Small Cell Lung Cancer Radiosensitivity
2025 · Molecular Cancer Therapeutics · 1 citations
https://doi.org/10.1158/1535-7163.mct-24-0978
T
Thomas J. Hayman
Yale University(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
74
Papers
874
Citations
14
h-index
19
i10-index
Thomas J. Hayman is an academic researcher from Yale University. The author has contributed to research in topics: PI3K/AKT/mTOR signaling in cancer & Lung Cancer Treatments and Mutations & RNA modifications and cancer. The author has an h-index of 14, co-authored 63 publications.
ORCID: 0000-0001-7046-2276Papers by this author
worksComplete vs. Incomplete Consolidative Radiotherapy in Patients with Extensive-Stage Small Cell Lung Cancer
2024 · International Journal of Radiation Oncology*Biology*Physics · 0 citations
https://doi.org/10.1016/j.ijrobp.2024.07.1890
Cardiac Toxicity Following SBRT for Centrally Located Lung Tumors: Assessing the Impact of Radiation Dose Metrics
2025 · International Journal of Radiation Oncology*Biology*Physics · 0 citations
https://doi.org/10.1016/j.ijrobp.2025.06.3759
P1.07.36 A Three-Gene Signature Predicting Local Recurrence in Stage I-III NSCLC Patients Treated With Radiation Therapy
2025 · Journal of Thoracic Oncology · 0 citations
https://doi.org/10.1016/j.jtho.2025.09.279
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat